The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation.
about
Redundancy in the World of MAP Kinases: All for OneERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?Remyelination Therapy in Multiple SclerosisMyelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoformsNG2 cells (polydendrocytes): listeners to the neural network with diverse propertiesMAPK pathway activation in pilocytic astrocytomaIdentification of VHY/Dusp15 as a regulator of oligodendrocyte differentiation through a systematic genomics approachTmeff2 is expressed in differentiating oligodendrocytes but dispensable for their differentiation in vivoThe extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review).Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelinationHeterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?Zinc and the ERK kinases in the developing brain.The thrombin receptor is a critical extracellular switch controlling myelination.The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.Translational control of myelin basic protein expression by ERK2 MAP kinase regulates timely remyelination in the adult brainErk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation.ERK2 Alone Drives Inflammatory Pain But Cooperates with ERK1 in Sensory Neuron SurvivalMyelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.The Orphan G Protein-coupled Receptor GPR17 Negatively Regulates Oligodendrocyte Differentiation via Gαi/o and Its Downstream Effector Molecules.ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination.Nucleus-localized 21.5-kDa myelin basic protein promotes oligodendrocyte proliferation and enhances neurite outgrowth in coculture, unlike the plasma membrane-associated 18.5-kDa isoformThe Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and MyelinationInterplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development.Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases.Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation.The antiaging protein Klotho enhances oligodendrocyte maturation and myelination of the CNS.Cholesterol Biosynthesis Supports Myelin Gene Expression and Axon Ensheathment through Modulation of P13K/Akt/mTor Signaling.NG2 cells in white matter but not gray matter proliferate in response to PDGF.Regulation of the timing of oligodendrocyte differentiation: mechanisms and perspectives.MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells.The crucial role of Erk2 in demyelinating inflammation in the central nervous system.Oligodendrogenesis after cerebral ischemia.Signaling through ERK1/2 controls myelin thickness during myelin repair in the adult central nervous system.Genetic evidence that Nkx2.2 and Pdgfra are major determinants of the timing of oligodendrocyte differentiation in the developing CNS.Aspirin promotes oligodendrocyte precursor cell proliferation and differentiation after white matter lesion.Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination.
P2860
Q26742080-00E309F0-C61D-4BE6-90FB-8CC3E6B67409Q26744787-9A188D96-C791-459B-9027-103E5E088610Q26772359-A49A813A-A66E-4C1C-894F-448B05D3C268Q26860265-F3C6111B-7DDF-44F5-900C-5408E705C7CDQ26863731-467898ED-F064-498B-847E-7771E6299061Q27006028-D472C57A-2992-4612-A98A-7B1A359002BCQ28727258-488312F2-5C98-4B52-A0DC-54D54C82A59FQ33671731-45A958F8-DC5C-46C3-9CB1-6923BF63A636Q33674924-A6112531-6668-4F18-82CF-71F990380285Q33731106-85D4652A-0C10-48C7-885C-36A30C2FC4E9Q33911142-D03BCE59-6B44-4C45-ACC2-4960EF1397FFQ34233708-495EBC49-E43B-4AFD-8C11-C7B3435F16E0Q35217740-36E5A9A2-1A07-4F09-856D-A7BDFB7F912BQ35294476-5E449AFB-B251-4F64-8029-8DF2EEC1CD2FQ35523618-3DEC034F-FAF1-40D2-94FD-F577CA9A5C7BQ35625755-2EE36CC2-7965-4756-B682-16149966D334Q35693398-EC47A885-DDF8-4F8E-AA34-232E63C67CB5Q35772949-BA1D5CB1-B052-4947-9FFE-8C9F21F07E5BQ35995980-DCE06F21-31E7-4BCE-B090-8A8F10C1F722Q36299698-7DFCF093-5333-44E2-9786-B57ED61F8355Q36442376-78D363AD-6918-4DE3-8DF3-432EFEA097E0Q36464562-B8A20D5C-EB56-4C0F-A3B5-C7B64128DF8EQ36601697-BDD37144-E1B8-4521-9574-ED7A40147123Q36665907-814E4F20-45B0-407D-8903-70B0DD83E82AQ36678075-4ECE5F31-EB41-4199-872E-51286F26A4EFQ36697506-740F4121-591B-4DC9-8A2E-FD99550C9C9AQ36732832-901F6D90-DF29-496E-8968-CD0E5FB4336AQ36798870-C714841F-2A7F-424C-9CE5-17C8DED5706DQ36940161-AA56BE84-B30D-4D9D-AE11-6A557E309495Q37012784-DB77287C-9590-4878-9216-B95EA7058781Q37110581-977B29AE-BCD1-4355-8EDF-401242283404Q37142091-E29DAE1B-DE09-4000-B3DC-509915E3002DQ37144056-B6736DEC-DBBC-407C-AE23-336DEFFE74DFQ37179748-6A0A874E-BC9F-4F7F-ADC3-C42FCA4EAF11Q37233328-C1B09045-E9DE-4FD3-99EC-13CC2EE9BCCEQ37261533-AA5BA0DD-FECD-40C6-A981-1122585EF1FCQ37325360-99A5B52F-0DD8-474C-B9B6-8D4020757E42Q37507612-ACBF4438-4592-4E2C-9316-FF82B9660A93Q37517131-CE8ACA67-02DB-46C0-8892-E370C890C972Q37557188-BA90AEAF-59D4-4247-BF16-2F3D4FF32F97
P2860
The ERK2 mitogen-activated protein kinase regulates the timing of oligodendrocyte differentiation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The ERK2 mitogen-activated pro ...... igodendrocyte differentiation.
@ast
The ERK2 mitogen-activated pro ...... igodendrocyte differentiation.
@en
type
label
The ERK2 mitogen-activated pro ...... igodendrocyte differentiation.
@ast
The ERK2 mitogen-activated pro ...... igodendrocyte differentiation.
@en
prefLabel
The ERK2 mitogen-activated pro ...... igodendrocyte differentiation.
@ast
The ERK2 mitogen-activated pro ...... igodendrocyte differentiation.
@en
P2093
P2860
P1476
The ERK2 mitogen-activated pro ...... igodendrocyte differentiation.
@en
P2093
Gary E Landreth
J Colleen Karlo
Robert H Miller
Sharyl L Fyffe-Maricich
P2860
P304
P356
10.1523/JNEUROSCI.3239-10.2011
P407
P577
2011-01-01T00:00:00Z